Description

Movinaza-20 (serratiopeptidase) Coated Enteric Tablets 20 mg. №30

Ingredients:

Each tablet contains 20 mg of serratiopeptidase.

Dosage:

The recommended dosage is one tablet taken orally, once a day on an empty stomach.

Indications:

Movinaza-20 is indicated for the management of inflammation and pain associated with various conditions such as arthritis, sinusitis, and post-operative swelling.

Contraindications:

Do not use Movinaza-20 if you are allergic to serratiopeptidase or any other ingredients in the tablet. Consult your healthcare provider before use if you are pregnant or breastfeeding.

Directions:

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence:

Serratiopeptidase, the active ingredient in Movinaza-20, is a proteolytic enzyme known for its anti-inflammatory and analgesic properties. Studies have shown that serratiopeptidase can help reduce swelling, pain, and improve tissue repair processes. Research published in the Journal of the Association of Physicians of India demonstrated the efficacy of serratiopeptidase in reducing post-operative swelling and pain.

Additional Information:

Movinaza-20 coated enteric tablets are designed to bypass the acidic environment of the stomach and release the active ingredient in the alkaline environment of the small intestine. This enteric coating ensures optimal absorption and effectiveness of the medication. It is important to store the tablets in a cool, dry place away from direct sunlight.

Consult your healthcare provider before starting Movinaza-20 to determine the appropriate dosage and duration of treatment based on your specific condition. If you experience any adverse reactions or side effects while taking this medication, discontinue use and seek medical attention immediately.